<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>1746-1596-2-S1-S7</ui>
   <ji>1746-1596</ji>
   <fm>
      <dochead>Oral presentation</dochead>
      <bibl>
         <title>
            <p>Sensitivity of an immunoglobulin heavy chain gene polymerase chain reaction primer system for routine diagnosis of lymphomas</p>
         </title>
         <aug>
            <au id="A1" ca="yes">
               <snm>Heyny-von Hau&#223;en</snm>
               <fnm>R</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A2">
               <snm>Braun</snm>
               <fnm>C</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Mall</snm>
               <fnm>G</fnm>
               <insr iid="I1"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Pathologisches Institut Klinikum Darmstadt, Darmstadt, Germany</p>
            </ins>
         </insg>
         <source>Diagnostic Pathology</source>
         <supplement>
            <title>
               <p>35te Tagung der Pathologen am Oberrhein/35th Meeting of Pathologists of the Upper Rhine Region (PATOR)</p>
            </title>
            <note>Meeting abstracts &#8211; A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1746-1596-2-S1-full.pdf">here</a>.</note>
         </supplement>
         <conference>
            <title>
               <p>35te Tagung der Pathologen am Oberrhein/35th Meeting of Pathologists of the Upper Rhine Region (PATOR)</p>
            </title>
            <location>The Institute of Pathology, University Hospital Freiburg, Germany</location>
            <date-range>1 July 2006</date-range>
         </conference>
         <issn>1746-1596</issn>
         <pubdate>2007</pubdate>
         <volume>2</volume>
         <issue>Suppl 1</issue>
         <fpage>S7</fpage>
         <url>http://www.diagnosticpathology.org/supplements/2/S7</url>
         <xrefbib>
            <pubid idtype="doi">10.1186/1746-1596-2-S1-S7</pubid>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>14</day>
               <month>3</month>
               <year>2007</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2007</year>
         <collab>Heyny-von Hau&#223;en et al; licensee BioMed Central Ltd.</collab>
      </cpyrt>
   </fm>
   <bdy>
      <sec>
         <st>
            <p>Aims</p>
         </st>
         <p>Polymerase chain reaction (PCR) and length fragment analyses of the immunoglobulin heavy chain (IgH) gene are useful tools for clonality assessment in malignant B-cell-lymphomas and reactive lymphoid infiltrates. The present investigation analyzes the sensitivity of an IgH gene consensus primer multiplex PCR system for the detection of clonality for routine diagnosis in 109 lymphomas during a period of 3 years (2003&#8211;2005) at the Institut of Pathology Klinikum Darmstadt.</p>
      </sec>
      <sec>
         <st>
            <p>Methods</p>
         </st>
         <p>We used FR2A/JH/VLJH and FR3A/JH/VLJH primer sets for detecting clonal B cell populations. Primer sequences used for PCR: Variable region FR2A consensus primer: FR2A: TGG(AG)TCCG(AC)CAG(GC) C(CT)(CT)C(AGCT)GG. Joining region (JH) consensus primer: LJH: TGAGGA GACGGTGACC, VLJH: GTGCAGGT(AGCT) CCTTGGCCCCAG-FAM. 1. PCR: FR2A/LJH and FR3A/LJH. 2. PCR: FR2A/VLJH-FAM and FR3A/VLJH-FAM. Fluorescence fragment analyses of IgH gene rearrangement were performed with FAM-labeled PCR products by high-resolution capillary electrophoresis using the ABI-PRISM 310 Genetic Analyzer (Applied Biosystems, Weiterstadt, Germany) with a POP 6-filled capillary (Applied Biosystems) and analyzed by using the GeneScan software (Applied Biosystems). A fragment was considered to be clonal in the case of a peak-height ratio (PHR) >2. The PHR was calculated as the quotient of the highest peak divided by the mean height of the two peaks surrounding the largest peak.</p>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <p>See Table <tblr tid="T1">1</tblr>.</p>
         <tbl id="T1">
            <title>
               <p>Table 1</p>
            </title>
            <caption>
               <p/>
            </caption>
            <tblbdy cols="2">
               <r>
                  <c ca="left">
                     <p>
                        <b>Lymphoma diagnosis</b>
                     </p>
                  </c>
                  <c ca="left">
                     <p>
                        <b>Detection of clonally rearranged IgH gene</b>
                     </p>
                  </c>
               </r>
               <r>
                  <c cspan="2">
                     <hr/>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>B lymphoblastic lymphoma</p>
                  </c>
                  <c ca="left">
                     <p>100% (1/1)</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>Mantle cell lymphoma</p>
                  </c>
                  <c ca="left">
                     <p>100% (3/3)</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>CLL</p>
                  </c>
                  <c ca="left">
                     <p>100% (24/24)</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>Lymphoplasmacytic lymphoma</p>
                  </c>
                  <c ca="left">
                     <p>100% (6/6)</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>Marginal zone B-cell lymphoma</p>
                  </c>
                  <c ca="left">
                     <p>100% (48/48)</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>Plasma cell myeloma</p>
                  </c>
                  <c ca="left">
                     <p>100% (1/1)</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>Hairy cell leukaemia</p>
                  </c>
                  <c ca="left">
                     <p>50% (1/2)</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>Follicular lymphoma</p>
                  </c>
                  <c ca="left">
                     <p>55% (6/11)</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>Diffuse large B-cell lymphoma</p>
                  </c>
                  <c ca="left">
                     <p>82% (9/11)</p>
                  </c>
               </r>
               <r>
                  <c ca="left">
                     <p>Hodgkin lymphoma</p>
                  </c>
                  <c ca="left">
                     <p>50% (1/2)</p>
                  </c>
               </r>
            </tblbdy>
         </tbl>
      </sec>
      <sec>
         <st>
            <p>Conclusion</p>
         </st>
         <p>The present study showed a variable sensitivity of PCR of IgH gene region with FR2A/JH/VLJH and FR3A/JH/VLJH consensus primer sets for different lymphomas. Sensitivity of our consensus primer set mainly depends on the existence of IgH gene rearrangements or the status of the IgH gene in the special lymphoma types, especially the occurrence of somatic hypermutation in variable-region genes.</p>
      </sec>
   </bdy>
</art>
